Publicaciones en las que colabora con JOSÉ JAVIER MEANA MARTÍNEZ (23)

2021

  1. Correction to: Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation (Pharmacological Reports, (2021), 73, 4, (1079-1095), 10.1007/s43440-021-00253-z)

    Pharmacological Reports

  2. Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1079-1095

  3. Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment

    European Neuropsychopharmacology, Vol. 42, pp. 12-21

  4. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2019

  1. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex

    Journal of Psychopharmacology, Vol. 33, Núm. 2, pp. 244-249

  2. Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463

2016

  1. Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence

    World Journal of Biological Psychiatry, Vol. 17, Núm. 4, pp. 308-315

2015

  1. Up-regulated 14-3-3β and 14-3-3ζ proteins in prefrontal cortex of subjects with schizophrenia: Effect of psychotropic treatment

    Schizophrenia Research, Vol. 161, Núm. 2-3, pp. 446-451

2014

  1. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: Differential effect of antidepressant treatment

    Journal of Affective Disorders, Vol. 167, pp. 343-350

2013

  1. Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment

    Psychopharmacology, Vol. 226, Núm. 1, pp. 177-188

2012

  1. Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers

    Neuropharmacology, Vol. 62, Núm. 2, pp. 1044-1051

  2. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

    Nature Neuroscience, Vol. 15, Núm. 9, pp. 1245-1254

2010

  1. Characterization of regulators of G-protein signaling RGS4 and RGS10 proteins in the postmortem human brain

    Neurochemistry International, Vol. 57, Núm. 7, pp. 722-729

2008

  1. Monoamine oxidase B activity is increased in human gliomas

    Neurochemistry International, Vol. 52, Núm. 1, pp. 230-234

2006

  1. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the μ-opioid receptor and I2-imidazoline binding sites

    Bioorganic and Medicinal Chemistry, Vol. 14, Núm. 19, pp. 6570-6580

2000

  1. Characterization of receptor-mediated [35S]GTPγS binding to cortical membranes from postmortem human brain

    European Journal of Pharmacology, Vol. 390, Núm. 1-2, pp. 25-36

1999

  1. Differential modulation of α2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment

    Life Sciences, Vol. 64, Núm. 25, pp. 2327-2339

1996

  1. [3H]RX821002 [2-methoxyidazoxan) binds to α2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney

    European Journal of Pharmacology, Vol. 316, Núm. 2-3, pp. 359-368

1995

  1. Increased density of μ-opioid receptors in the postmortem brain of suicide victims

    Brain Research, Vol. 682, Núm. 1-2, pp. 245-250

1994

  1. μ-Opioid receptor and α2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts

    Psychopharmacology, Vol. 115, Núm. 1-2, pp. 135-140